Accepted for/Published in: JMIR mHealth and uHealth
Date Submitted: Jul 15, 2019
Open Peer Review Period: Jul 18, 2019 - Sep 12, 2019
Date Accepted: Jan 24, 2020
(closed for review but you can still tweet)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preparing African American men to make informed prostate cancer screening decisions: Development and pilot test of PCSPrep
ABSTRACT
Background:
African American men are at higher risk of developing and dying from prostate cancer compared to Caucasian men. The serum prostate-specific antigen (PSA) screening test has a high risk of false positive results and is not routinely recommended. Rather, men are encouraged to make individual decisions about screening with their medical providers, after being fully informed about its potential benefits, limitations, and risks.
Objective:
We developed and pilot-tested an online, interactive DA (PCSPrep) among African American men to promote informed decision-making using a pre-post-test evaluation design. A convenience sample of n=47 men aged 45-70 with no history of prostate cancer was recruited from community settings. Participants used PCSPrep and completed online surveys that assessed outcomes, including prostate cancer screening knowledge, decisional conflict, and preparation for decision-making.
Methods:
We developed and pilot-tested an online, interactive DA (PCSPrep) among African American men to promote informed decision-making using a pre-post-test evaluation design. A convenience sample of n=47 men aged 45-70 with no history of prostate cancer was recruited from community settings. Participants used PCSPrep and completed online surveys that assessed outcomes, including prostate cancer screening knowledge, decisional conflict, and preparation for decision-making.
Results:
Use of PCSPrep was associated with a significant increase in prostate cancer knowledge (49% vs 60%; p=0.007) and fewer men rated their risk of developing prostate cancer to be less likely than men of their age (75% vs 67%, p=0.078) after using the tool. Men also experienced increased decisional conflict (70 vs 79%; p=0.02). No changes in screening preferences were observed. Most (81%) reported that using PCSPrep prepared them for informed/shared decision-making.
Conclusions:
PCSPrep was an acceptable DA that improved men’s feeling of being prepared for decision-making, although it also raised decisional conflict for men. Clinical Trial: Clinicaltrials.gov NCT02787434
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.